Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mecamylamine for Depression and Alcohol Dependence
NCT00563797Phase 3Completed
- Sponsor
- Yale University
- Start
- Aug 2007
- Primary completion
- Jul 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of mecamylamine in major depressive disorder (MDD), alcohol dependence, sponsored by Yale University. Started Aug 2007; status: completed.
02
Drugs
mecamylamine
03
Conditions
major depressive disorder (MDD)alcohol dependence
Beyond the preview
Go deeper on NCT00563797.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00563797.